(IN BRIEF) Merck KGaA, Darmstadt, Germany, has entered into a licensing agreement with Inspirna, Inc. for ompenaclid (RGX-202), a first-in-class oral inhibitor of the creatine transport channel SLC6A8, and SLC6A8-targeting follow-on compounds, currently under Phase II evaluation for the second-line … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged colorectal cancer, Dr. Usman “Oz” Azam, ERBITUX, Inspirna, Merck KGaA, ompenaclid (RGX-202), partnership, sustainability, USA, Victoria Zazulina
(IN BRIEF) Novo Nordisk has announced separate research collaborations with Omega Therapeutics and Cellarity Inc. to explore innovative treatment approaches for obesity and MASH (Metabolic Associated Fatty Liver Disease). The collaboration with Omega aims to develop an epigenomic controller to … Read the full press release
Posted in Business, Denmark, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Cellarity Inc., Fabrice Chouraqui, innovative, Mahesh Karande, Marcus Schindler, MASH (Metabolic Associated Fatty Liver Disease), Novo Nordisk, Obesity, Omega Therapeutics, partnership, Paul Biondi, sustainability, treatments, USA
(IN BRIEF) Researchers at the University of Warwick, in collaboration with other institutions and charities, are leading a groundbreaking initiative to improve the diagnosis and treatment of Obstructive Sleep Apnoea (OSA). OSA often goes undiagnosed, leading to sleep disturbances and … Read the full press release
(IN BRIEF) QIAGEN, a leading provider of molecular diagnostics and life sciences solutions, is significantly expanding its operations in the Middle East region. In early 2024, the company will open its regional headquarters in Riyadh, Saudi Arabia, to strengthen its … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged Middle East, Oman, partnership, QIAGEN, Riyadh HQ, Saudi Ministry of Health, Simona Grandits, sustainability, TB Screening Initiative
(IN BRIEF) The University of Helsinki’s international master’s programs for 2024 received an impressive 12,665 applications from 10,662 applicants. The Master’s Program in Computer Science was the most sought after with 1,402 applications, followed closely by the Master’s Program in … Read the full press release
(IN BRIEF) AstraZeneca has announced its definitive agreement to acquire Gracell Biotechnologies Inc. (NASDAQ: GRCL), a global biopharmaceutical company specializing in cell therapies for cancer and autoimmune diseases. This strategic move aims to bolster AstraZeneca’s presence in the field of … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged acquisition, Adrian Kemp, AstraZeneca, cell therapy, Dr. William Cao, Gracell Biotechnologies, Gracell's GC012F, partnership, Susan Galbraith, sustainability
(IN BRIEF) The European Investment Bank (EIB) has signed a €12.5 million venture debt agreement with Swedish medical company BrainCool AB, specializing in medical cooling solutions. BrainCool is pioneering body cooling technologies that have the potential to revolutionize care standards … Read the full press release
Posted in Banks, Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Luxembourg, Management, News, Science, Sweden, Technology
Tagged BrainCool AB, Cooling Technologies, EIB, innovative, Martin Waleij, partnership, sustainability, Thomas Östros
(IN BRIEF) Sanofi has announced the discontinuation of the global clinical development program for tusamitamab ravtansine, following an interim analysis of the Phase 3 CARMEN-LC03 trial. The trial assessed tusamitamab ravtansine as a monotherapy in previously treated metastatic non-squamous non-small … Read the full press release
Posted in Business, France, Healthcare, Industrial, Management, News, Pharma & Biotech, Science
Tagged Dietmar Berger, NSCLC, Sanofi, Tusamitamab Ravtansine
(IN BRIEF) SGS’s flammability testing laboratory in Farmingdale, New York, has received approval from the United States Coast Guard (USCG) as an Accepted Independent Laboratory. This accreditation allows SGS to offer a comprehensive range of flammability testing, inspection, and certification … Read the full press release
(IN BRIEF) Roche has announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application (sBLA) for Xolair® (omalizumab) under Priority Review. The sBLA is for the reduction of allergic reactions, including anaphylaxis, caused by … Read the full press release
Posted in Business, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged adults, allergic reactions, CHILDREN, FDA approval, Levi Garraway, Multiple Foods, Reducing, Roche, Xolair®
(IN BRIEF) The Delft Bioengineering Institute (BEI) has announced the winners of its annual cross-campus competition for MSc students who excelled in their graduation projects in bioengineering. In 2023, three students—Thomas Michalica, Linde Spoelstra, and Thomas Mooijman—stood out for their … Read the full press release
(IN BRIEF) The Delft Bioengineering Institute (BEI) has selected six outstanding interdisciplinary research projects for funding in the field of bioengineering. These projects, which received €20,000 each, encompass a wide range of innovative topics, including the detection of tumor-derived DNA … Read the full press release
(IN BRIEF) Almirall S.A., a global pharmaceutical company specializing in medical dermatology, has confirmed its involvement in the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, taking place from January 8th to 11th, 2024. Carlos Gallardo, Chairman and CEO … Read the full press release
Posted in Business, Healthcare, Industrial, Management, Media, News, Pharma & Biotech, Science, Spain, Technology
Tagged 42nd Annual J.P. Morgan Healthcare Conference, Almirall, Carlos Gallardo, San Francisco
(IN BRIEF) Tim Slangen, a PhD researcher at the TU/e Department of Electrical Engineering, has conducted extensive research on the phenomenon of supraharmonic disturbances related to electric vehicle (EV) charging. Supraharmonics are waveform distortions in voltage and current occurring at … Read the full press release
Posted in Automotive, Business, Education, Energy, Gas & Oil, Environment, Financial, Industrial, Infrastructure & Utilities, Investment, Management, Netherlands, News, Science, Technology
Tagged ElaadNL, electric vehicle charging, partnership, Power Quality Challenges, researcher, supraharmonic, sustainability, Tim Slangen, TU/e
(IN BRIEF) Researchers at Eindhoven University of Technology (TU/e) have made a significant breakthrough in the early detection of esophageal cancer through the use of artificial intelligence (AI). Over a decade of research led by Fons van der Sommen has … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Science, Technology
Tagged AI, Early Esophageal Cancer Detection, endoscopy, Erik Schoon, Fons van der Sommen, Jacques Bergman, Peter de With, researchers, TU/e, wellness
(IN BRIEF) The University of Twente’s Executive Board has appointed Prof. Dr. Ir. J.W.M. (Hans) Hilgenkamp as the new scientific director of the MESA+ institute, effective February 1, 2024. Hilgenkamp, a distinguished expert in applied physics and nanotechnology, will take … Read the full press release
(IN BRIEF) The European grant scheme Interreg has awarded over €1.2 million to the University of Twente (UT) research project BRIDGE, which is dedicated to cross-border healthcare cooperation. Scheduled to commence in spring 2024, BRIDGE aims to map ongoing initiatives, … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, Netherlands, News, Science
Tagged BRIDGE Project, Caroline Fischer, Gréanne Leeftink, Healthcare Cooperation, Interreg, Le Anh Long, Manon Bruens, Oliver Treib, University of Twente, Vincent Hofbauer, Vittoria Chimisso
(IN BRIEF) In a time marked by disruptions in education for over 5.3 million children due to the ongoing war in Ukraine, Star For Life Ukraine, a non-profit organization, is dedicated to promoting informal tech education. The aim is to … Read the full press release
Posted in Education, Non Profit, Science, Society, Technology, Ukraine
Tagged Blockchain, charity, Computer for Kids, Education, Empowering Ukrainian children, gender equality, Girls in Tech project, inclusiveness, IT skills, Kateryna Tkachenko, mental health, scholarship, Scratch Lab for kids, Star for Life Ukraine, Summer Tech Camps, tech education, Tech Labs, Tech School, UKRAINE, Ukrainian tech talents, war in Ukraine
(IN BRIEF) Researchers at PSI have made a surprising discovery that could expand the medical applications of botulinum toxin A1, commonly known as Botox. They have developed antibody-like proteins called DARPins that unexpectedly accelerate the toxin’s impact on nerve signal … Read the full press release
Posted in Business, Education, Healthcare, Industrial, Management, News, Science, Switzerland, Technology
Tagged Botox, DARPins, Medical Treatments PSI, Oneda Leka, proteins
(IN BRIEF) BioNTech has achieved a significant milestone in expanding mRNA vaccine manufacturing in Africa with the inauguration of its Kigali site, which includes the first manufacturing unit known as BioNTainer. This move is part of BioNTech’s broader efforts to … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Africa, BioNTainer, BioNTech, Dr. Jean Kaseya, H.E. Macky Sall, H.E. Paul Kagame, H.E. Ursula von der Leyen, Hon. Annalena Baerbock, Moussa Faki Mahamat, mRNA Vaccine, Prof. Ugur Sahin, Rwanda, Sierk Poetting, vaccine
(IN BRIEF) EQT X fund has announced its acquisition of Zeus Company Inc., a pioneer in the design and production of fluoropolymer tubing for medical devices and select industrial applications. The acquisition aims to support Zeus’ continued growth as a … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, News, Science, Sweden, Technology
Tagged acquisition, EQT, Eric Liu, Ethan Waxman, John Groetelaars, medical device, partnership, Steve Peterson, Zeus Company
(IN BRIEF) GSK plc has announced positive results from Part 2 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III trial, evaluating the use of Jemperli (dostarlimab) in combination with standard chemotherapy and as maintenance therapy for patients with primary advanced or recurrent endometrial … Read the full press release
Posted in Business, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged chomotherapy, dostarlimab, Endometrial Cancer Trial, GSK, Hesham Abdullah, RUBY, Zejula
(IN BRIEF) A study led by researchers from the University of Cambridge and King’s College London highlights the importance of valuing patients’ “lived experiences” in the diagnostic process. The research, involving over 1,000 patients and clinicians, revealed that clinicians often … Read the full press release
Posted in Business, Education, Healthcare, Industrial, Management, News, Science, Technology, United Kingdom
Tagged 'Lived Experiences', Diagnosis Process, Dr Tom Pollak, King’s College London, Melanie Sloan, neuropsychiatric lupus, partnership, Recognition of Patients', study, Sue Farrington, sustainability, University of Cambridge
(IN BRIEF) The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMAs) have jointly released a comprehensive Artificial Intelligence (AI) workplan outlining their collaborative strategy through 2028. This initiative aims to maximize the benefits of AI for stakeholders … Read the full press release
Posted in Artificial Intelligence (AI), Business, Environment, European Union, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged 2028 Workplan, artificial-intelligence, EMA, HMAs, Medicines Regulation, partnership, sustainability
(IN BRIEF) Roche (SIX: RO, ROG; OTCQX: RHHBY) has once again secured its position as one of the leading sustainable companies in the Pharmaceuticals sector within the Dow Jones Sustainability Indices (DJSI). In the latest rankings, Roche secured the third … Read the full press release
(IN BRIEF) Iberdrola, a major energy company, has received recognition as the world’s leading private utility for investment in innovation and development, marking its second consecutive year of achievement in this regard. The European Commission’s report, ‘The 2023 Industrial R&D … Read the full press release
(IN BRIEF) The European Investment Bank (EIB) has signed a €20 million venture debt financing agreement with The Akkermansia Company, a Belgian microbiome health specialist, supported by the European Commission’s InvestEU initiative. The Akkermansia Company, originating as a spin-off from … Read the full press release
Posted in Banks, Belgium, Business, Economy, Environment, Financial, Government, Industrial, Investment, Luxembourg, Management, News, Pharma & Biotech, Science, Technology
Tagged Akkermansia Company, Belgium, EIB, financing, Kris Peeters, Michael Oredsson, Microbiome Health Research, partnership, sustainability
(IN BRIEF) Novadip, a Belgian biotech company, has secured €18 million in venture debt financing from the European Investment Bank (EIB) with support from the European Union’s InvestEU initiative. The funds will be utilized for clinical trials of NVD-003, an … Read the full press release
(IN BRIEF) The TU/e Young Academy of Engineering (EYAE) has welcomed four new members who will serve a four-year term, contributing to the advancement of knowledge exchange, research funding, and closer collaborations between industry and the university. The new members … Read the full press release
(IN BRIEF) Novozymes and Chr. Hansen have unveiled their new collective name, ‘Novonesis,’ symbolizing a fresh beginning in the world of biosolutions. This announcement marks a significant step towards the merger of the two companies. Novonesis, which means ‘A new … Read the full press release
Posted in Business, Denmark, Industrial, Management, News, Pharma & Biotech, Science, Technology
Tagged 'Novonesis', biology, biosolutions, Cees de Jong, Chr. Hansen, Ester Baiget, Novozymes, partnership
(IN BRIEF) Roche, a global pharmaceutical company, has shared compelling data from its CD20xCD3 T-cell engaging bispecific antibody program during the 65th American Society of Hematology (ASH) Annual Meeting & Exposition held in December 2023. The data includes extended follow-up … Read the full press release
(IN BRIEF) In a significant development, GSK plc has received marketing authorization from the European Commission (EC) for Jemperli (dostarlimab) in combination with carboplatin-paclitaxel chemotherapy as a treatment option for adult patients suffering from mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) … Read the full press release
(IN BRIEF) In the Phase 3 IsKia trial presented at the American Society of Hematology (ASH) Annual Meeting, Sarclisa® (isatuximab) combined with carfilzomib, lenalidomide, and dexamethasone (KRd) demonstrated a significant improvement in achieving minimal residual disease (MRD) negativity among newly … Read the full press release
Posted in Business, Education, Financial, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged carfilzomib, Combination Therapy, dexamethasone, Francesca Gay, lenalidomide, Myeloma, Peter C. Adamson, Phase 3 Trial, Remission Rates, Sanofi, Sarclisa
(IN BRIEF) Roche has released positive long-term follow-up data from the Phase III KATHERINE study, evaluating Kadcyla® (trastuzumab emtansine) as adjuvant therapy for people with HER2-positive early-stage breast cancer (eBC) who have residual invasive disease following neoadjuvant treatment. The study … Read the full press release
Posted in Business, Healthcare, Industrial, Management, News, Science, Switzerland, Technology
Tagged breast cancer, HER2-Positive, Kadcyla, Levi Garraway, Long-Term Survival, Phase III KATHERINE, Prof. Dr. Sibylle Loibl, Roche
(IN BRIEF) Roche has announced promising results from the Phase III INAVO120 study, which evaluated inavolisib in combination with palbociclib (Ibrance®) and fulvestrant as a first-line treatment for individuals with PIK3CA-mutated, hormone receptor (HR)-positive, HER2-negative, endocrine-resistant, locally advanced, or metastatic … Read the full press release
(IN BRIEF) BioNTech, a leading biotechnology company, has formalized a multi-year strategic partnership with the State of Victoria in Australia, building upon a prior Letter of Intent established in October 2022. The collaboration aims to strengthen the local mRNA ecosystem … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Australia, BioNTainers, BioNTech, mRNA Ecosystem, partnership, Prof. Ugur Sahin, Sierk Poetting, sustainability, Victoria
(IN BRIEF) The COMBINE-CT consortium, led by Philips and supported by a €6.5 million grant from the Innovative Health Initiative (IHI), is dedicated to improving the diagnosis and treatment of coronary artery disease (CAD). CAD, characterized by the accumulation of … Read the full press release
(IN BRIEF) NWO’s Executive Board has announced the appointment of Prof. Dr. Guda van Noort and Dr. Nicky Pouw, both from the University of Amsterdam, to the Board of the Social Science and Humanities (SSH) Domain. Guda van Noort is … Read the full press release
Posted in Business, Education, Industrial, Management, Netherlands, News, Science, Technology
Tagged Antal van den Bosch, appointment, Dr. Nicky Pouw, Jasmin Lange, Jeroen de Ridder, leadership, Margaretha Wewerinke Singh, Mathieu Segers, NWO, Odile Heynders, Prof. Dr. Guda van Noort, Sander Thomaes, Sjef Barbiers, SSH Domain Board, University of Amsterdam Professors
(IN BRIEF) Sanofi is showcasing its ambitious pipeline transformation strategy, which includes a record 12 potential blockbuster opportunities currently under clinical evaluation. Among these, there are nine innovative medicines and vaccines with peak sales potential ranging from €2 to €5 … Read the full press release
Posted in Business, France, Healthcare, Industrial, Management, Media, News, Pharma & Biotech, Science, Technology
Tagged Houman Ashrafian, Immunology Industry, Paul Hudson, Sanofi
(IN BRIEF) The Phase 3 IMROZ trial, assessing the use of Sarclisa® (isatuximab) in combination with standard-of-care bortezomib, lenalidomide, and dexamethasone (VRd), has achieved its primary efficacy endpoint at a planned interim analysis. The trial demonstrated a statistically significant improvement … Read the full press release
Posted in Business, France, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, Technology
Tagged Dietmar Berger, IMROZ trial, Multiple Myeloma Patients, Sanofi, Sarclisa, Thierry Facon
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
